tirzepatide injection brand name Mounjaro (Tirzepatide) for Weight Loss India Compound Tirzepatide
Description
How well do GLP-1 medications work for weight loss
June 26th, 2024: Study reveals GLP-1 drugs may cause bone density loss without exercise A recent study from the University of Copenhagen raises new concerns about GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, highlighting potential bone density loss
The wider availability of this drug is likely to herald the beginning of a step change in the global treatment of obesity and metabolic diseases
Final Advice: Always research before buying
The injection site also matters
La tirzepatida est contraindicada en pacientes con antecedentes personales o familiares de CMT o en pacientes con MEN 2
